Tscan Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $427k | 73k | 5.83 |